Abstract
There is clear clinical evidence that tumours in anaemic patients are difficult to control with radiotherapy. We have studied the radiosensitivity of two transplantable mouse tumours, the SCCVII/St carcinoma and the KHT sarcoma in hosts made anaemic either with an iron poor diet or as a result of tumour growth. The haemoglobin level and haematocrits of mice on the low iron diet fell to about 60% of normal within 11 weeks. The number of clonogenic cells after a single X-ray dose of 20 Gy was slightly lower (P less than 0.05) in the anaemic animals (2.3 X 10(4) g-1) than in controls (5.2 X 10(4) g-1) though there was no significant difference in the surviving fractions. Mice bearing KHT tumours became anaemic with haematocrits falling to 65% of normal as their tumours grew from 300-1200 mg. A second 'test' tumour was implanted one week after the first 'anaemia-inducing' tumour so that estimates of radiosensitivity could all be carried out on tumours within the same size range (150-300 mg). Radiosensitivity was significantly greater in the most anaemic hosts with 2.2 X 10(4) cells g-1 surviving a dose of 20 Gy compared with 6.7 x 10(4) g-1 in controls (P less than 0.01). These results are consistent with most published data for mouse tumours though not for many human tumours.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bush R. S. The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys. 1986 Nov;12(11):2047–2050. doi: 10.1016/0360-3016(86)90146-x. [DOI] [PubMed] [Google Scholar]
- Dische S., Anderson P. J., Sealy R., Watson E. R. Carcinoma of the cervix--anaemia, radiotherapy and hyperbaric oxygen. Br J Radiol. 1983 Apr;56(664):251–255. doi: 10.1259/0007-1285-56-664-251. [DOI] [PubMed] [Google Scholar]
- Fazekas J. T., Scott C., Marcial V., Davis L. W., Wasserman T., Cooper J. S. The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers: based on RTOG trial #79-15. Int J Radiat Oncol Biol Phys. 1989 Dec;17(6):1177–1181. doi: 10.1016/0360-3016(89)90523-3. [DOI] [PubMed] [Google Scholar]
- Hewitt H. B., Blake E. R. Effect of induced host anaemia on the viability and radiosensitivity of murine malignant cells in vivo. Br J Cancer. 1971 Jun;25(2):323–336. doi: 10.1038/bjc.1971.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hill R. P., Bush R. S., Yeung P. The effect of anaemia on the fraction of hypoxic cells in an experimental tumour. Br J Radiol. 1971 Apr;44(520):299–304. doi: 10.1259/0007-1285-44-520-299. [DOI] [PubMed] [Google Scholar]
- Hirst D. G. Anemia: a problem or an opportunity in radiotherapy? Int J Radiat Oncol Biol Phys. 1986 Nov;12(11):2009–2017. doi: 10.1016/0360-3016(86)90139-2. [DOI] [PubMed] [Google Scholar]
- Hirst D. G., Brown J. M., Hazlehurst J. L. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain. Br J Cancer. 1982 Jul;46(1):109–116. doi: 10.1038/bjc.1982.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hirst D. G., Wood P. J. The adaptive response of mouse tumours to anaemia and retransfusion. Int J Radiat Biol Relat Stud Phys Chem Med. 1987 Apr;51(4):597–609. doi: 10.1080/09553008414552131. [DOI] [PubMed] [Google Scholar]
- Jung C., Müller-Klieser W., Vaupel P. Tumor blood flow and O2 availability during hemodilution. Adv Exp Med Biol. 1984;180:281–291. doi: 10.1007/978-1-4684-4895-5_27. [DOI] [PubMed] [Google Scholar]
- Kallman R. F., Silini G., Van Putten L. M. Factors influencing the quantitative estimation of the in vivo survival of cells from solid tumors. J Natl Cancer Inst. 1967 Sep;39(3):539–549. [PubMed] [Google Scholar]
- McCormack M., Nias A. H., Smith E. Chronic anaemia, hyperbaric oxygen and tumour radiosensitivity. Br J Radiol. 1990 Oct;63(754):752–759. doi: 10.1259/0007-1285-63-754-752. [DOI] [PubMed] [Google Scholar]
- Overgaard J., Hansen H. S., Andersen A. P., Hjelm-Hansen M., Jørgensen K., Sandberg E., Berthelsen A., Hammer R., Pedersen M. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study. Int J Radiat Oncol Biol Phys. 1989 Apr;16(4):1065–1068. doi: 10.1016/0360-3016(89)90917-6. [DOI] [PubMed] [Google Scholar]
- Rojas A., Stewart F. A., Smith K. A., Soranson J. A., Randhawa V. S., Stratford M. R., Denekamp J. Effect of anemia on tumor radiosensitivity under normo and hyperbaric conditions. Int J Radiat Oncol Biol Phys. 1987 Nov;13(11):1681–1689. doi: 10.1016/0360-3016(87)90165-9. [DOI] [PubMed] [Google Scholar]
- Sevick E. M., Jain R. K. Viscous resistance to blood flow in solid tumors: effect of hematocrit on intratumor blood viscosity. Cancer Res. 1989 Jul 1;49(13):3513–3519. [PubMed] [Google Scholar]
- Siemann D. W., Alliet K. L., Macler L. M. Manipulations in the oxygen transport capacity of blood as a means of sensitizing tumors to radiation therapy. Int J Radiat Oncol Biol Phys. 1989 May;16(5):1169–1172. doi: 10.1016/0360-3016(89)90276-9. [DOI] [PubMed] [Google Scholar]
- Siemann D. W., Hill R. P., Bush R. S., Chhabra P. The in vivo radiation response of an experimental tumor: the effect of exposing tumor-bearing mice to a reduced oxygen environment prior to but not during irradiation. Int J Radiat Oncol Biol Phys. 1979 Jan;5(1):61–68. doi: 10.1016/0360-3016(79)90039-7. [DOI] [PubMed] [Google Scholar]
- Tanaka N., Maeda M., Hasegawa M. [The influence of anemia on the radiation effect in transplanted tumours. Studies on the fructose sarcoma]. Nihon Igaku Hoshasen Gakkai Zasshi. 1969 Apr;29(1):49–54. [PubMed] [Google Scholar]
